Literature DB >> 7515201

Fluconazole therapy in transplant recipients receiving FK506.

R Mañez1, M Martin, D Raman, D Silverman, A Jain, V Warty, I Gonzalez-Pinto, S Kusne, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7515201      PMCID： PMC2956419          DOI： 10.1097/00007890-199405270-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  13 in total

1.  Interaction between cyclosporine and fluconazole in renal allograft recipients.

Authors:  D M Canafax; N M Graves; D M Hilligoss; B C Carleton; M J Gardner; A J Matas
Journal:  Transplantation       Date:  1991-05       Impact factor: 4.939

2.  Interaction between FK506 and clotrimazole in a liver transplant recipient.

Authors:  L Mieles; R Venkataramanan; I Yokoyama; V J Warty; T E Starzl
Journal:  Transplantation       Date:  1991-12       Impact factor: 4.939

3.  A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.

Authors:  J Fung; K Abu-Elmagd; A Jain; R Gordon; A Tzakis; S Todo; S Takaya; M Alessiani; A Demetris; O Bronster
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  FK 506 in clinical kidney transplantation.

Authors:  R Shapiro; M Jordan; V Scantlebury; J Fung; C Jensen; A Tzakis; J McCauley; P Carroll; C Ricordi; A J Demetris
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Pharmacokinetics of FK 506 in transplant patients.

Authors:  R Venkataramanan; A Jain; V S Warty; K Abu-Elmagd; M Alessiani; J Lever; A Krajak; J Flowers; S Mehta; S Zuckerman
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation.

Authors:  J M Armitage; R L Kormos; J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

7.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

Authors:  J L Goodman; D J Winston; R A Greenfield; P H Chandrasekar; B Fox; H Kaizer; R K Shadduck; T C Shea; P Stiff; D J Friedman
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

8.  Fungal infections in liver transplant recipients.

Authors:  C P Wajszczuk; J S Dummer; M Ho; D H Van Thiel; T E Starzl; S Iwatsuki; B Shaw
Journal:  Transplantation       Date:  1985-10       Impact factor: 4.939

9.  Efficacy of fluconazole in the treatment of systemic fungal infections.

Authors:  D Milatovic; A Voss
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

10.  Clinical spectrum of fungal infections after orthotopic liver transplantation.

Authors:  P Castaldo; R J Stratta; R P Wood; R S Markin; K D Patil; M S Shaefer; A N Langnas; E C Reed; S J Li; T J Pillen
Journal:  Arch Surg       Date:  1991-02
View more
  18 in total

1.  Tacrolimus interaction with clotrimazole: a concise case report and literature review.

Authors:  Mary Choy
Journal:  P T       Date:  2010-10

2.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 3.  [Strategies for antifungal treatment failure in intensive care units].

Authors:  C Arens; M Bernhard; C Koch; A Heininger; D Störzinger; T Hoppe-Tichy; M Hecker; B Grabein; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2015-09       Impact factor: 1.041

Review 4.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

Review 5.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

Review 6.  Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.

Authors:  P E Wallemacq; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

7.  Coccidioidomycosis in liver transplant recipients relocating to an endemic area.

Authors:  Janis E Blair; David D Douglas
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 8.  Endemic Mycoses in Solid Organ Transplant Recipients.

Authors:  Jeremy S Nel; Luther A Bartelt; David van Duin; Anne M Lachiewicz
Journal:  Infect Dis Clin North Am       Date:  2018-09       Impact factor: 5.982

Review 9.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

Review 10.  Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

Authors:  K L Goa; L B Barradell
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.